| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jul―28 |
Exploring the therapeutic efficacy: Unveiling the active compounds of Huashi Baidu granules against COVID-19 |
Chuanxi Tian, Jinyue Zhao, Qian Wang, Keke Luo, Shuang Zhao, Li Wan, Jiarui Li, Kaile Ma, Yanyan Zhou, Min Li |
| 2 |
[GO] |
2024―Mar―08 |
Characterization of polycyclic aromatic hydrocarbon from open burning of disposable COVID-19 facemask: Spatial distribution and risk assessment |
Olusola Adedayo Adesina, Raymond Opara, Biodun Adewale, Lala Mayowa, Jacob Sonibare |
| 3 |
[GO] |
2024―Jan―24 |
Deciphering the potential therapeutic targets and mechanisms of jaranol for the treatment of COVID-19 and lung adenocarcinoma |
Zhongcui Kang, Qian Wu, Qihang Peng, Yiting Deng, Hongxia Xu, Yu Xiao, Jingda Li, Shaobin Li, Jin Li, Ying Chen |
| 4 |
[GO] |
2024―Jan―09 |
First report on the QSAR modelling and multistep virtual screening of the inhibitors of nonstructural protein Nsp14 of SARS-CoV-2: reducing unnecessary chemical synthesis and experimental tests |
Qianqian Wang, Tengjiao Fan, Runqing Jia, Na Zhang, Lijiao Zhao, Rugang Zhong, Guohui Sun |
| 5 |
[GO] |
2023―Dec―28 |
Design of new dipeptide inhibitors against SARS-CoV 3CLpro: 3D-QSAR, molecular docking, MD simulation, ADMET studies and retrosynthesis strategy |
Esslali Soukaina, Liman Wissal, Koubi Yassine, El Allali Achraf, Farhate Guenoun, Mohammed Bouachrine |
| 6 |
[GO] |
2023―Dec―07 |
Deciphering the mechanism of Ephedra Herba-Armeniacae Semen Amarum herb pairs on COVID-19 by integrated network pharmacology and bioinformatics |
Zhuoxi Wang, Jifang Ban, He Wang, Rui Qie, Yabin Zhou |
| 7 |
[GO] |
2023―Nov―28 |
Potential inhibition of SARS-CoV-2 infection and its mutation with the novel Geldanamycin analogue: Ignaciomycin |
Antony Stalin, Pachaiyappan Saravana Kumar, Balakrishnan Senthamarai Kannan, Rajamanikam Saravanan, Savarimuthu Ignacimuthu, Quan Zou |
| 8 |
[GO] |
2023―Oct―27 |
Synthesis, In Silico and In Vitro Studies of Novel Quinazolinone Derivatives as Potential SARS-CoV-2 3CLpro Inhibitors |
Mubarak A. Alamri, Obaid Afzal, Md Jawaid Akhtar, Shahid Karim, Mohammed Husain, Manal A. Alossaimi, Yassine Riadi |
| 9 |
[GO] |
2023―Oct―20 |
Computational screening of potential bromodomain-containing protein 2 inhibitors for blocking SARS-CoV-2 infection through pharmacophore modeling, molecular docking and molecular dynamics simulation |
Shaohua Xu, Huicheng Yuan, Ling Li, Kai Yang, Liangcun Zhao |
| 10 |
[GO] |
2023―Sep―25 |
From ancient remedy to modern medicine: Artemisia argyi sesquiterpenoids as a promising natural treatment for COVID-19 |
Yujing Huang, Zhilin Huang, YuHui Gan, Juntao Xie, Zhiyun Xia, Liu Tao, Xiangyu Chen, Xiangguang Li, Haibo Zhou, Pinghua Sun, Zhe Ren, Yifei Wang, Junxia Zheng |
| 11 |
[GO] |
2023―Jun―08 |
A suitable drug structure for interaction with SARS-CoV-2 main protease between Boceprevir, Masitinib and Rupintrivir; a molecular dynamics study |
Mehdi Yoosefian, Razieh Dashti, Mohamad Mahani, Leila Montazer, Amirabbas Mir |
| 12 |
[GO] |
2023―May―18 |
Screening compounds for treating the diabetes and COVID-19 from Miao medicine by molecular docking and bioinformatics |
Feng Xu, Xulong Huang, Hongmei Wu, Xiangpei Wang |
| 13 |
[GO] |
2023―May―17 |
Identification of Potential Indonesian Marine Invertebrate Bioactive Compounds as TMPRSS2 and SARS-CoV-2 Omicron Spike Protein Inhibitors through Computational Screening |
Haviani Rizka Nurcahyaningtyas, Alfrina Irene, Joko Tri Wibowo, Masteria Yunovilsa Putra, Arry Yanuar |
| 14 |
[GO] |
2023―Apr―28 |
Compounds from Myrtle Flowers as Antibacterial Agents and SARS-CoV-2 Inhibitors: In-vitro and Molecular Docking Studies |
Badra Barhouchi, Rafik Menacer, Saad Bouchkioua, Amira Mansour, Nadjah Belattar |
| 15 |
[GO] |
2023―Mar―06 |
Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology |
Feifei Sun, Jinde Liu, Ali Tariq, Zhonglei Wang, Yongning Wu, Lin Li |
| 16 |
[GO] |
2023―Feb―15 |
COVID-19 Chloroquine Drug Detection Using Novel, Highly Sensitive SnO2-Based Electrochemical Sensor |
Ayman AbdelHamid, Abdelaziz Elgamouz, Monther Khanfer, Abdel-Nasser Kawde |
| 17 |
[GO] |
2023―Feb―08 |
In silico study of Novel Niclosamide Derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates |
Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H Wu, Hsu-Shan Huang |
| 18 |
[GO] |
2022―Nov―30 |
Chloroquine Chaos and COVID-19: Smart delivery perspectives through pH sensitive polymers/ micelles and ZnO nanoparticles |
Anju Manuja, Balvinder Kumar, Dharvi Chhabra |
| 19 |
[GO] |
2022―Oct―19 |
Microwave Assisted Synthesis of 2-amino-4-chloro-pyrimidine Derivatives: Anticancer and Computational Study on Potential Inhibitory Action against COVID-19 |
Faiza Qureshi, Muhammad Nawaz, Soleiman Hisaindee, Sarah Ameen Almofty, Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, Nisar Ullah, Muhammad Taha, Ohood Alshehri, Bader Huwaimel, Mohammed Khaled Bin Break |
| 20 |
[GO] |
2022―Oct―12 |
Pharmacophore model-aided virtual screening combined with comparative molecular docking and molecular dynamics for identification of marine natural products as SARS-CoV-2 papain-like protease inhibitors |
Neelaveni Thangavel, Mohammed Albratty |
| 21 |
[GO] |
2022―Sep―15 |
One-pot synthesis, X-ray crystal structure, and identification of potential molecules against COVID-19 main protease through structure-guided modeling and simulation approach |
Youness El Bakri, Malahat Musrat Kurbanova, Sabir Ali Siddique, Sajjad Ahmad, Souraya Goumri-Said |
| 22 |
[GO] |
2022―Aug―06 |
Ecofriendly and sustainable Sargassum spp.-based system for the removal of highly used drugs during the COVID-19 pandemic |
J. Luis López-Miranda, Gustavo A. Molina, Rodrigo Esparza, Marlen Alexis González-Reyna, Rodolfo Silva, Miriam Estévez |
| 23 |
[GO] |
2022―Jul―11 |
Synthesis and Greener Pastures Biological Study of Bis-thiadiazoles as Potential Covid-19 Drug Candidates |
Musa A. Said, Sayed M. Riyadh, Nadia S. Al-Kaff, A.A. Nayl, Khaled D. Khalil, Stefan Bräse, Sobhi M. Gomha |
| 24 |
[GO] |
2022―May―31 |
Fluorescence spectrophotometry for COVID-19 determination in clinical swab samples |
Kartika A. Madurani, Suprapto Suprapto, Muhammad Yudha Syahputra, Ika Puspita, Abdul Hadi Furqoni, Listya Puspasari, Hafildatur Rosyidah, Agus Muhamad Hatta, Juniastuti Juniastuti, Maria Inge Lusida, Masato Tominaga, Fredy Kurniawan |
| 25 |
[GO] |
2022―Apr―27 |
Prediction of COVID-19 manipulation by selective ACE inhibitory compounds of Potentilla reptant root: In silico study and ADMET profile |
Yuan Xu, Mahmood Al-Mualm, Ermias Mergia Terefe, Maksuda Ilyasovna Shamsutdinova, Maria Jade Catalan Opulencia, Fahad Alsaikhan, Abduladheem Turki Jalil, Ali Thaeer Hammid, Ayesheh Enayati, Hassan Mirzaei, Vahid Khori, Ali Jabbari, Aref Salehi, Alireza Soltani, Abdullah Mohamed |
| 26 |
[GO] |
2021―Dec―10 |
Development of superior antibodies against the S-protein of SARS-Cov-2 using macrocyclic epitopes |
Hassan Traboulsi, Mohammed A. Khedr, Rafea Elgorashe, Yasair Al-Faiyz, Amr Negm |
| 27 |
[GO] |
2021―Dec―01 |
Computational Screening and Biochemical Analysis of Pistacia Integerrima and Pandanus Odorifer Plants To Find Effective Inhibitors Against Receptor-Binding Domain (RBD) of the Spike Protein of SARS-Cov-2 |
Gobindo Kumar Paul, Shafi Mahmud, Afaf A Aldahish, Mirola Afroze, Suvro Biswas, Swagota Briti Ray Gupta, Mahmudul Hasan Razu, Shahriar Zaman, Md. Salah Uddin, Mohammed H Nahari, Mohammed Merae Alshahrani, Mohammed Abdul Rahman Alshahrani, Mala Khan, Md. Abu Saleh |
| 28 |
[GO] |
2021―Nov―28 |
A possible Potential COVID-19 Drug Candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of Disordered Independent Molecules of a Novel Crystal Structure, HSA/DFT/XRD and cytotoxicity |
Mohcine Missioui, Musa A. Said, Güneş Demirtaş, Joel T. Mague, Ahlam Al-Sulami, Nadia S. Al-Kaff, Youssef Ramli |
| 29 |
[GO] |
2021―Aug―23 |
Potential bioactive compounds as SARS-COV-2 inhibitors from extracts of the marine red alga Halymenia durvillei (Rhodophyta) - A computational study |
Asmi Citra Malina A.R. Tassakka, Ophirtus Sumule, Muhammad Nasrum Massi, Marianti Manggau, Israini Wiyulanda Iskandar, Jamaluddin Fitrah Alam, Andi Dian Permana, Lawrence Manzano Liao |
| 30 |
[GO] |
2021―Aug―16 |
Scoping Insight on Antiviral Drugs Against COVID-19 |
Ahmed S Ali, Ibrahim M Ibrahim, Abdulhadi S Burzangi, Ragia H. Ghoneim, Hanin S Aljohani, Hamoud A Alsamhan, Jehan Barakat |
| 31 |
[GO] |
2021―Jul―28 |
Exploring the interaction of quercetin-3-O-sophoroside with SARS-CoV-2 main proteins by theoretical studies: a probable prelude to control some variants of coronavirus including Delta |
Suliman Khan, Arif Hussain, Yasaman Vahdani, Hamideh Kooshki, Bashdar Mahmud Hussen, Setareh Haghighat, Mohammed Fatih Rasul, Hazha Jamal Hidayat, Anwarul Hasan, Zehra Edis, Samir Haj Bloukh, Shahab Kasravi, Mohammad Mahdi Nejadi Babadaei, Majid Sharifi, Qian Bai, Jianbo Liu, Bowen Hu, Keivan Akhtari, Mojtaba Falahati |
| 32 |
[GO] |
2021―Jul―14 |
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study |
Shafi Mahmud, Suvro Biswas, Gobindo Kumar Paul, Mohasana Akter Mita, Shamima Afrose, Md. Robiul Hasan, Mst. Sharmin Sultana Shimu, Mohammad Abu Raihan Uddin, Md. Salah Uddin, Shahriar Zaman, K.M. Kaderi Kibria, Md. Arif Khan, Talha Bin Emran, Md. Abu Saleh |
| 33 |
[GO] |
2021―Jun―08 |
Quantitative Structure-Property Relationships (QSPR) of Valency Based Topological Indices with Covid-19 drugs and Application |
Jian-Feng Zhong, Abdul Rauf, Muhammad Naeem, Jafer Rahman, Adnan Aslam |
| 34 |
[GO] |
2021―Feb―25 |
Structure- and Ligand-Based In silico Studies toward the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2 |
Marwa A.A. Fayed, Mohammed Farrag El-Behairy, Inas A. Abdallah, Hend Mohamed Abdel-Bar, Hanan Elimam, Ahmed Mostafa, Yassmin Moatasim, Khaled A. M Abouzid, Yaseen A. M. M. Elshaier |
| 35 |
[GO] |
2021―Jan―12 |
Pharmacological basis for the potential role of Azithromycin and Doxycycline in management of COVID-19 |
Ahmed S. Ali, Mai A. ASattar, Shahed Kareem, Dina Kutbi, Hanin Aljohani, Duaa Bakhshwin, Mohammed Alsieni, Huda M. Alkreathy |
| 36 |
[GO] |
2020―Oct―01 |
TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): potential therapeutic intervention to combat COVID-19 |
Mohammad Azam Ansari, Qazi Mohammad Sajid Jamal, Suriya Rehman, Ahmad Almatroudi, Mohammad A. Alzohairy, Mohammad N. Alomary, Takshashila Tripathi, Ali H Alharbi, Syed Farooq Adil, Mujeeb Khan, M. Shaheer Malik |
| 37 |
[GO] |
2020―Aug―09 |
Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics |
Mubarak A. Alamri, Ali Altharawi, Alhumaidi B. Alabbas, Manal A. Alossaimi, Safar M. Alqahtani |
|
